Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Treatment for major acute

Specific treatments for major acute ischemic stroke... [Pg.257]

The acute toxic properties of all the organochlorine pesticides in humans are qualitatively similar. These agents interfere with inactivation of the sodium channel in excitable membranes and cause rapid repetitive firing in most neurons. Calcium ion transport is inhibited. These events affect repolarization and enhance the excitability of neurons. The major effect is central nervous system stimulation. With DDT, tremor may be the first manifestation, possibly continuing to convulsions, whereas with the other compounds convulsions often appear as the first sign of intoxication. There is no specific treatment for the acute intoxicated state, and management is symptomatic. [Pg.1217]

Stroke is the leading cause of major long-term disability in adults and the third leading cause of death in the United States. On average, a new stroke occurs every 45 seconds. Thrombolytic therapy with intravenous recombinant tissue-plasminogen activator (IV rt-PA) is the most effective treatment for acute ischemic stroke. In this chapter, we review the rationale for thrombolysis in acute ischemic stroke, clinical evidence supporting the use of thrombolytics, and the application of thrombolysis in practice. [Pg.39]

Bauer M et al. (2002). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 1 Acute and continuation treatment of major depressive disorder. World Journal of Biological Psychiatry, 3, 5-43. [Pg.185]

The efficacy of psychotherapy and antidepressants is considered to be additive. Psychotherapy alone is not recommended for the acute treatment of patients with severe and/or psychotic major depressive disorders. For uncomplicated nonchronic major depressive disorder, combined treatment may provide no unique advantage. Cognitive therapy, behavioral therapy, and interpersonal psychotherapy appear to be equal in efficacy. [Pg.793]

The existence of the blood-brain barrier is an important consideration in the chemotherapy of neoplastic diseases of the brain or meninges. Poor drug penetration into the CNS has been a major cause of treatment failure in acute lymphocytic leukemia in children. Treatment programs for this disease now routinely employ craniospinal irradiation and intrathecally administered methotrexate as prophylactic measures for the prevention of relapses. The testes also are organs in which inadequate antitumor drug distribution can be a cause of relapse of an otherwise responsive tumor. [Pg.634]

It is important to note that specific psychotherapies (CBT or IPT) (Brent et ah, 1997 Mufson et ah, 1999) are also reasonable initial choices for the acute treatment of a youth with the first noncomplicated episode of major depression. Nevertheless, if patients are treated with psychotherapy alone, pharmacotherapy... [Pg.470]

Discontinuation of antidepressant medication should be concordant with the guidelines for treatment duration (see Acute Major Depression subsection in the preceding section). It is advisable to taper the dose while monitoring for signs and symptoms of relapse. Abrupt discontinuation is also more likely to lead to antidepressant discontinuation symptoms, often referred to as withdrawal symptoms. The occurrence of these symptoms after medication discontinuation does not imply that antidepressants are addictive. [Pg.61]

Anxiolytics are the treatment of choice for anxiety disorders, and antipsychotics should not be used for this purpose. Previously, psychotropics were classified as major (i.e., antipsychotics) and minor (i.e., anxiolytics) tranquilizers, a categorization we now know to be conceptually incorrect. There is evidence, however, that adding benzodiazepines (BZDs) to antipsychotics might improve the treatment of various acute psychotic episodes complicated by agitation, although this has not been well studied (see Chapter 5 and Chapter 10). [Pg.49]

Our approach to both acute and maintenance therapy is consistent with the American Psychiatric Association guidelines for the treatment of major depressive disorder in adults (292). [Pg.136]

The FDA indication for the use of the antidepressants in the treatment of major depression is fairly broad. Most antidepressants are approved for both acute and long-term treatment of major depression. Acute episodes of MDD tend to last about 6-14 months untreated but at least 20% of episodes last 2 years or longer. [Pg.662]

This was systematically studied with DWI in 62 consecutive patients who presented with a classic lacunar syndrome (Ay et al. 1999). DWI showed subsidiary acute lesion(s) in addition to the index lacunar lesion in ten patients (16%). The additional lesions were punctuate and lay within the leptomen-ingeal arterial territories in the majority. Patients with subsidiary infarction(s) more frequently harbored an embolic cause of stroke. This finding is critical because underlying embolic cause may give rise to recurrent strokes with more extensive brain injury. Identification of subsidiary infarctions on DWI should have an impact in prompting the physician to introduce the best effective treatment for secondary stroke prevention in a patient with lacunar infarction. [Pg.199]

Glassman, A. H., O Connop C. M., Califf, R., Swedberg, K., Schwartz, R, Bigger, J. T., Jr., et al., for the Sertraline Antidepressant Heart Attack Randomized Trial Group. (2002). Setraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701-709. [Pg.294]

LaRue LJ, Alter M, Traven ND et al. (1988). Acute stroke therapy trials problems in patient accrual. Stroke 19 950-954 Marshall M, Lockwood A, Bradley C et al. (2000). Unpublished rating scales a major source of bias in randomised controlled trials of treatments for schizophrenia British Journal of Psychiatry 176 249-252 Medical Research Council Working Party (1985). MRC trial of treatment of mild... [Pg.237]

The general treatments described in this chapter are applicable to all patients with acute major stroke regardless of etiology. Specific treatment for ischemic and hemorrhagic stroke is discussed in Chs. 21 and 22, respectively. Therapy for acute stroke can be divided into ... [Pg.250]

Some degree of recovery occurs in the majority of patients after stroke, and complete recovery is possible although the prognosis is difficult to predict in an individual patient. Rehabilitation to aid recovery and enable the patient to develop strategies for coping with disability forms the mainstay of treatment after the acute stroke period. [Pg.274]


See other pages where Treatment for major acute is mentioned: [Pg.174]    [Pg.780]    [Pg.278]    [Pg.63]    [Pg.142]    [Pg.580]    [Pg.1400]    [Pg.199]    [Pg.147]    [Pg.480]    [Pg.72]    [Pg.146]    [Pg.317]    [Pg.321]    [Pg.441]    [Pg.214]    [Pg.15]    [Pg.134]    [Pg.1351]    [Pg.363]    [Pg.251]    [Pg.90]    [Pg.140]    [Pg.310]    [Pg.348]    [Pg.239]   


SEARCH



Specific treatments for major acute ischemic stroke

Treatment for acute

Treatment for major acute ischemic stroke

© 2024 chempedia.info